Prelude Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,800	Closed	-$28.9K	–	1374
2024 Q3	$28.9K	Buy	1,800 +437	+32%	+$7.03K	﹤0.01%	1126
2024 Q2	$33.2K	Buy	+1,363	New	+$33.2K	﹤0.01%	1071